CHRNA7 and colitis: Treatment with PNU-282987 in vivo was able to reduce the loss of crypts, goblet cells, and mucosal damage at the histopathological level; therefore, the therapeutic effect of α7nAChR agonist in a colitis mouse model was suggested.